These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 1708046)

  • 21. [A comparative study of the efficacy of lisinopril versus quinapril in controlling light to moderate arterial hypertension. A follow-up with ABPM].
    Motero Carrasco J
    Rev Esp Cardiol; 1995 Nov; 48(11):746-53. PubMed ID: 8532944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The safety and efficacy of quinapril in the treatment of mild to moderate essential hypertension.
    Frishman WH
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII19-25. PubMed ID: 2189617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled multicenter study with quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension.
    Romero R; Castellote E; Ocón J; Wagner B
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):114-8. PubMed ID: 7564350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of arterial thrombogenesis by quinapril but not losartan.
    Bavry AA; Li D; Zander DS; Phillips MI; Mehta JL
    J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):121-7. PubMed ID: 11150391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute and long-term effects of angiotensin converting enzyme inhibition on larger arteries and cardiac hypertrophy: mechanical and structural parameters.
    Benetos A; Albaladejo P; Levy BI; Safar ME
    J Hypertens Suppl; 1994 Jul; 12(4):S21-9. PubMed ID: 7965270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can an angiotensin-converting enzyme inhibitor with a short half-life effectively lower blood pressure for 24 hours?
    Palatini P
    Am Heart J; 1992 May; 123(5):1421-5. PubMed ID: 1575169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats.
    Arvola P; Ruskoaho H; Wuorela H; Pekki A; Vapaatalo H; Pörsti I
    Br J Pharmacol; 1993 Apr; 108(4):980-90. PubMed ID: 8485636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of quinapril hydrochloride in patients with essential hypertension and impaired renal function.
    Owada A; Nonoguchi H; Terada Y; Marumo F; Tomita K
    Clin Exp Hypertens; 1997 May; 19(4):495-502. PubMed ID: 9140710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet hyperactivity in hypertensive older patients is controlled by lowering blood pressure.
    Riondino S; Pignatelli P; Pulcinelli FM; Lenti L; Di Veroli C; Marigliano V; Gazzaniga PP
    J Am Geriatr Soc; 1999 Aug; 47(8):943-7. PubMed ID: 10443854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Conversion from oral ACE inhibitor to intravenous quinaprilat administration in mild to moderate essential hypertension].
    Schmidt BM; Smilde J; Oldenbroek C; Wehling M
    Med Klin (Munich); 1998 Dec; 93(12):701-6. PubMed ID: 10024837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of isradipine on platelet function in hypertension at rest and during exercise.
    Fitscha P; Virgolini I; Rauscha F; Sinzinger H
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):178S-180S. PubMed ID: 1827015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinapril and blood lipids.
    Koskinen P; Manninen V; Eisalo A
    Br J Clin Pharmacol; 1988 Oct; 26(4):478-80. PubMed ID: 3190999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of quinapril in the elderly patient.
    Schnaper HW
    Am J Hypertens; 1990 Nov; 3(11):278S-282S. PubMed ID: 2261146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic and morphological effects of quinapril during genetic hypertension development.
    Richer C; Mulder P; Fornes P; Richard V; Camilleri JP; Giudicelli JF
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):631-42. PubMed ID: 1724542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
    Culy CR; Jarvis B
    Drugs; 2002; 62(2):339-85. PubMed ID: 11817979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of quinapril and triamterene/hydrochlorothiazide on cardiac and vascular end-organ damage in isolated systolic hypertension.
    Heesen WF; Beltman FW; Smit AJ; May JF; de Graeff PA; Havinga TK; Schuurman FH; van der Veur E; Meyboom-de Jong B; Lie KI
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):187-94. PubMed ID: 9475259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial.
    Mokwe E; Ohmit SE; Nasser SA; Shafi T; Saunders E; Crook E; Dudley A; Flack JM
    Hypertension; 2004 Jun; 43(6):1202-7. PubMed ID: 15117912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACE inhibitors in the treatment of hypertension in the older patient.
    Canter D; Frank G
    Eur Heart J; 1990 May; 11 Suppl D():33-43. PubMed ID: 2193809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The treatment of mild to moderate hypertension with ACE inhibitors.
    Taylor SH
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S24-8. PubMed ID: 1691403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.